Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials.
about
Adult Stem Cell Therapy for Cardiac Repair in Patients After Acute Myocardial Infarction Leading to Ischemic Heart Failure: An Overview of Evidence from the Recent Clinical Trials.Thrombospondins: A Role in Cardiovascular Disease.Cardiac stem cell trials and the new world of cellular reprogramming: Time to move on.Cigarette Smoking Impairs Adipose Stromal Cell Vasculogenic Activity and Abrogates Potency to Ameliorate Ischemia.Cardiac Progenitor Cells in Basic Biology and Regenerative Medicine.
P2860
Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials.
@en
Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials.
@nl
type
label
Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials.
@en
Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials.
@nl
prefLabel
Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials.
@en
Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials.
@nl
P2860
P356
P1433
P1476
Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials
@en
P2093
Richard Wang
P2860
P304
P356
10.1155/2017/9404057
P5008
P577
2017-01-17T00:00:00Z